Sign Up to like & get recommendations! 0
Published in 2025 at "American Journal of Hematology"
DOI: 10.1002/ajh.27716
Abstract: Cystatin C (CysC) has emerged as a novel and potentially more reliable biomarker for the estimation of glomerular filtration in the general population in patients with various conditions. In AL amyloidosis, the current renal staging… read more here.
Sign Up to like & get recommendations! 3
Published in 2023 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3618
Abstract: To investigate whether metabolic syndrome (MetS) could predict renal outcome in patients with established chronic kidney disease (CKD). read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Prenatal Diagnosis"
DOI: 10.1002/pd.5263
Abstract: To compare the prognostic value of fetal serum biochemistry and fetal urine biochemistry in predicting renal outcome in lower urinary tract obstruction (LUTO). read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Pediatric Nephrology"
DOI: 10.1007/s00467-020-04501-x
Abstract: Background Children presenting with proliferative lupus nephritis (LN) are treated with intensified immunosuppressive protocols. Data on renal outcome and treatment toxicity is scare. Methods Twelve-month renal outcome and comorbidity were assessed in 79 predominantly Caucasian… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Rheumatology"
DOI: 10.1007/s10067-017-3721-7
Abstract: Clinical and histological factors have been identified as predictors of early and late renal outcome in ANCA-associated vasculitides (AAV). The presence and severity of kidney involvement at diagnosis are associated with poor prognosis in both… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical and Experimental Medicine"
DOI: 10.1007/s10238-021-00703-1
Abstract: Mesangial IgM deposition is found in patients with immunoglobulin A nephropathy (IgAN). This study aims to investigate the relationships between mesangial IgM deposition and disease progression in IgAN patients. A total of 1239 patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Journal of Nephrology"
DOI: 10.1007/s40620-023-01858-8
Abstract: Absolute treatment benefits—expressed as numbers needed to treat—of the glucose lowering and cardiovascular drugs, glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose transporter 2 (SGLT2) inhibitors on renal outcomes remain uncertain. With the present meta-analysis of… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfae069.1738
Abstract: Exercise reduced risk of diabetes and obesity. However, it remains unclear whether the pattern changes of exercise are increased risk of end-stage renal disease in new-onset diabetes mellitus (DM) patients. We assessed diabetes development in… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfw350
Abstract: Background Lowe syndrome (LS) and Dent-2 disease (DD2) are disorders associated with mutations in the OCRL gene and characterized by progressive chronic kidney disease (CKD). Here, we aimed to investigate the long-term renal outcome and… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keab818
Abstract: OBJECTIVE To develop a short-term renal outcome prediction model for acute kidney injury (AKI) in patients with lupus nephritis. METHODS Two lupus AKI cohorts from 2 independent centers during 2013-2019 were included, i.e., a derivation… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Therapeutic Apheresis and Dialysis"
DOI: 10.1111/1744-9987.13935
Abstract: This study aimed to investigate the role of mean platelet volume (MPV) in predicting renal outcome in acute kidney injury (AKI) developing on pre‐existing chronic kidney disease (CKD). read more here.